SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011011
Filing Date
2018-08-06
Accepted
2018-08-06 16:16:43
Documents
89
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 1259046
2 ex10-3.htm EX-10.3 90593
3 ex10-4.htm EX-10.4 77692
4 ex31-1.htm EX-31.1 18040
5 ex31-2.htm EX-31.2 17347
6 ex32-1.htm EX-32.1 7451
  Complete submission text file 0001493152-18-011011.txt   5449683

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE immy-20180630.xml EX-101.INS 863079
8 XBRL SCHEMA FILE immy-20180630.xsd EX-101.SCH 54044
9 XBRL CALCULATION FILE immy-20180630_cal.xml EX-101.CAL 87981
10 XBRL DEFINITION FILE immy-20180630_def.xml EX-101.DEF 284376
11 XBRL LABEL FILE immy-20180630_lab.xml EX-101.LAB 359719
12 XBRL PRESENTATION FILE immy-20180630_pre.xml EX-101.PRE 338285
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 18994941
SIC: 2834 Pharmaceutical Preparations